PP2Cη inhibitors are chemical compounds that specifically target the phosphatase activity of the enzyme PP2Cη (Protein Phosphatase 2Cη). PP2Cη belongs to the PP2C family of serine/threonine phosphatases, which are characterized by their requirement for magnesium or manganese ions as cofactors. These phosphatases play an essential role in various cellular processes, particularly in dephosphorylation events that regulate signal transduction pathways. PP2Cη, like other PP2C family members, is involved in maintaining the balance of phosphorylation states in proteins, which is critical for controlling cellular responses to environmental stimuli, including stress and growth factors. The selective inhibition of PP2Cη is of significant biochemical interest because this enzyme's activity is tightly linked to key regulatory processes, including cellular differentiation and proliferation.
The inhibitors of PP2Cη are designed to interfere with the catalytic domain of the enzyme, typically by blocking the interaction with its metal ion cofactors or by competing with its substrate-binding sites. Structurally, these inhibitors are diverse, and they often feature complex scaffolds that allow for high-affinity binding to the PP2Cη active site. By disrupting the normal function of PP2Cη, these compounds can modulate the phosphorylation state of downstream targets, affecting various biochemical pathways such as those related to stress responses, metabolic regulation, and cell cycle control. The study of PP2Cη inhibitors has led to deeper insights into the mechanistic roles of this enzyme in cellular physiology, offering valuable tools for probing the dynamic processes that underpin cellular regulation and signal transduction.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical may cause hypomethylation of the PP2Cη gene promoter, potentially leading to a decrease in its transcriptional initiation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylase activity, this compound could lead to hyperacetylation of histones near the PP2Cη gene, resulting in transcriptional repression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
As a DNA methyltransferase inhibitor, 5-Aza-2′-Deoxycytidine could lead to the demethylation of the PP2Cη gene promoter, which may decrease gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
This HDAC inhibitor may promote the acetylation of histones at the PP2Cη gene locus, potentially reducing the initiation of transcription for this gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By targeting mTOR signaling, this compound could decrease the translation of key regulators necessary for PP2Cη gene expression. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
This kinase inhibitor may disrupt the Ras/Raf/MEK/ERK pathway, potentially leading to a reduction in transcription factors that drive PP2Cη expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
By inhibiting cyclin-dependent kinases, flavopiridol could reduce the phosphorylation of transcriptional machinery, resulting in decreased PP2Cη gene transcription. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
This proteasome inhibitor could lead to the accumulation of misfolded proteins, triggering a cellular response that may include the downregulation of PP2Cη expression. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Thalidomide could downregulate PP2Cη expression by promoting the degradation of transcription factors specific to the PP2Cη gene through the ubiquitin-proteasome pathway. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $49.00 $367.00 $2030.00 | 18 | |
This thalidomide analogue could decrease the transcription of PP2Cη by enhancing the degradation of specific transcription factors involved in its gene expression. |